November 17, 2017 07:38 AM EST
Financing
Startups

What's a suc­cess­ful fail­ure? At­las' Booth sounds taps for Mer­ck-backed Quar­tet Med­i­cine

John Carroll

Editor & Founder

At­las Ven­ture sound­ed taps for biotech start­up Quar­tet Med­i­cine this morn­ing — done in by a trou­bling tox sig­nal that scut­tled its plans to de­vel­op a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

No­vo Nordisk’s once-dai­ly he­mo­phil­ia drug Al­he­mo ap­proved in US

A service from the Financial Times